Orpitaz 4000mg/500mg Injection
Marketer
Orville Biotek
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Orpitaz 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection is a dual-antibiotic formulation indicated for treating diverse bacterial infections. Its mechanism involves microbial eradication. Administration should always be performed by a qualified medical practitioner; self-injection is strictly prohibited. Dosage and frequency are determined by your physician, tailored to the infection's severity. Adhere meticulously to your doctor's prescribed regimen. Common adverse reactions may include gastrointestinal upset (nausea, vomiting, diarrhea) and skin reactions (rash). Injection site reactions such as localized pain, swelling, or erythema are also possible. Persistent or worsening side effects warrant immediate medical consultation. Prior to commencing treatment, disclose any antibiotic allergies, renal, or hepatic impairments to your doctor; dose adjustments or alternative therapies may be necessary. Under medical guidance, this medication is generally deemed safe for use during pregnancy and lactation.
Uses of Orpitaz 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Orpitaz 4000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Orpitaz 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Orpitaz 4000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Orpitaz 4000mg/500mg Injection works:
Orpitaz Injection, containing 4000mg of piperacillin and 500mg of tazobactam, employs a dual-drug mechanism. Piperacillin, an antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering piperacillin's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from co-ingesting alcohol and Orpitaz 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Orpitaz (4000mg/500mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data in humans, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injection Orpitaz, 4000mg/500mg, poses no known breastfeeding safety risk. Research in humans indicates minimal drug transfer to breast milk, presenting no apparent danger to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Orpitaz 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
The administration of Orpitaz 4000mg/500mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Orpitaz 4000mg/500mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Orpitaz 4000mg/500mg Injection in patients with liver impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Orpitaz 4000mg/500mg Injection :
Should you inadvertently omit a scheduled dose of Orpitaz 4000mg/500mg Injection, seek immediate medical advice.
Facts to Know About Orpitaz 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently